Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-18-041732
Filing Date
2018-08-03
Accepted
2018-08-02 17:36:39
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tv500020_10qa.htm 10-Q/A 177222
2 EXHIBIT 31.1 tv500020_ex31-1.htm EX-31.1 10634
3 EXHIBIT 31.2 tv500020_ex31-2.htm EX-31.2 10670
4 EXHIBIT 32.1 tv500020_ex32-1.htm EX-32.1 4337
5 EXHIBIT 32.2 tv500020_ex32-2.htm EX-32.2 4246
  Complete submission text file 0001144204-18-041732.txt   2563207

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celz-20180331.xml EX-101.INS 400738
7 XBRL TAXONOMY EXTENSION SCHEMA celz-20180331.xsd EX-101.SCH 35129
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20180331_cal.xml EX-101.CAL 26527
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20180331_def.xml EX-101.DEF 238167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20180331_lab.xml EX-101.LAB 233569
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20180331_pre.xml EX-101.PRE 250794
Mailing Address 2017 W PEORIA AVENUE PHOENIX AZ 85029
Business Address 2017 W PEORIA AVENUE PHOENIX AZ 85029 (602) 680-7439
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53500 | Film No.: 18989716
SIC: 2836 Biological Products, (No Diagnostic Substances)